Abstract
The primary function of the exocrine pancreas is the secretion of amylolytic, lipolytic, and proteolytic enzymes into the duodenum in response to the alimentary stimulus. The almost instinctive tendency to administer pancreatic enzymes to patients with pancreatic disease and secondary functional insufficiency is therefore not surprising, so that enzymatic activity in the small intestine can remain sufficient to prevent and/or to treat maldigestion of foods. However, although an oral enzyme replacement of this kind has for quite a long time been available, many reviews [1–4] have pointed out the lack of a rational therapy based on sound physiologic measurements. This explains the existence of numerous pharmacologic preparations, different dosages used, frequent variability of their administration, and the difference in clinical results obtained. Even authoritative textbooks, both of pharmacology and gastroenterology [5, 6], do not prove to be entirely pertinent, thus confirming how slow they are to assimilate data deriving from new scientific developments or from the controlled clinical trials [7]. It is in the light of this recent information that in the following paragraphs we shall discuss which enzymatic preparations are suitable for use, and how and when to administer them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Littman A, Hanscom DH (1969) Pancreatic extracts. N Engl J Med 281:201–204
Schneider R, Sammons HG, Beale D (1970) Pancreatic enzyme therapy. Br Med J 2:735–736
Saunders JHB, Wormsley KG (1975) Pancreatic extracts in the treatment of pancreatic exocrine insufficiency. Gut 16:157–162
Dobrilla G (1978) Enzimi pancreatici: valutazione critica del loro ruolo terapeutico. Ital J Gastroenterol 10:21s–24s
Harvey SC (1975) Gastric antacids and digestants. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan New York, p 971
Spiro HM (1977) Clinical gastroenterology, 2nd edn. Macmillan, New York, pp 1043–1070
Sturdevant RAL (1977) How should results of controlled trials affect clinical practice? Gastroenterology 73:1179–1180
Knill-Jones RP, Pearce H, Batten J, Williams R (1970) Comparative trial of Nutrizym in chronic pancreatic insufficiency. Br Med J 4:21–24
Berndt W (1978) Pankreasenzymsubstitution. Tierische oder pflanzliche Enzyme? In: Bartelheimer H, Classen M, Ossenberg FW (eds) Die Behandlung der kranken Bauchspeicheldrüse. Thieme, Stuttgart, p 79
Ruysen R (1969) Assay method of the F. I. P. Commission on pharmaceutical enzymes. In: Ruysen R. (ed) Symposium on pharmaceutical enzymes and their assay. Universitaire Pers, Ghent, p 99
Drummond S, Saunders JHB, Leach R, Wormsley KG (1977) Enzymic activities of commercial preparations of pancreatic enzymes. Scott Med J 22:221–224
Giulian BB, Singh LM, Mansfield AO (1967) Treatment of pancreatic exocrine insufficiency. 1. In vitro lipolytic activities of pancreatic lipase and fifteen commercial pancreatic supplements. Ann Surg 165:564–570
Pairent FW, Howard JM (1975) Pancreatic exocrine insufficiency. IV. The enzyme content of commercial pancreatic supplements. Arch Surg 110:739–741
Ihse I, Lilja P (1979) Pancreatic enzymic activities of commercial pancreatic enzymes preparations incubated in human small intestinal juice. Digestion 19:48–51
Graham DY (1977) Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relation between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. N Engl J Med 296:1315–1317
Di Magno EP, Malagelada JR, Go VLW, Moertel CG (1977) Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 296:1318–1322
Heizel WD, Cleaveland CR, Iber FL (1965) Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270
Peterson WL, Sturdevant RAL, Frankl HD, Richardson CT, Isenberg JI, Elashoff JD, Sones JQ, Gross RA, McCallum RW, Fordtran JS (1977) Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345
Ippoliti AF, Sturdevant RAL, Isenberg JI, Binder M, Camacho R, Cano R, Cooney C, Kline MM, Koretz RL, Meyer JH, Samloff IM, Schwabe AD, Strom EA, Valenzuela JE, Wintroub RH (1978) Cimetidine versus intersive antacid therapy for duodenal ulcer. A multicenter trial. Gastroenterology 74:393–395
Potryk D (1970) Intestinal obstruction from impacted antacid tablets. N Engl J Med 283:134–138 A
Burnett CH, Commons RR, Albright F, Howard JE (1949) Hypercalcaemia without hypercalciuria on hypophosphataemia calcinosis and renal insufficiency; syndrome following prolonged intake of milk and alkali. N Engl J Med 240:787–789
Ivey KY (1975) Anticholinergics: do they work in peptic ulcer? Gastroenterology 68:154–166
Regan PT, Malagelada JR, Di Magno EP, Go VLW (1978) Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 53:79–83
Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1977) Comparative effects of antacids, Cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858
Bianchi Porro G, Dolcini R, Grossi E, Petrillo M, Prada A (1977) Cimetidine in treatment of pancreatic insufficiency. Lancet 2:878–879
Dobrilla G, Bonoldi MC, Chilovi F (1980). Effects of Cimetidine on pancreatic function and disease. In: Torsoli A, Lucchelli PE, Brimblecombe RW (ed) Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamin research. Excerpta Medica, Amsterdam, pp 140–152
Ahuja AS, Mann NM (1978) Cimetidine in cystic fibrosis. Arch Dis Child 53:766
Cox KL, Isenberg JN, Osher AB, Dooley RR (1978) The effect of Cimetidine on pancreatic replacement therapy in the maldigestion of cystic fibrosis. Cystic fibrosis club (Abstr). Pediatr Res 12:433A
Hubbard VS, Dunn GD, Lester LA, Sant’Agnese PA (1979) Effectiveness of Cimetidine in patients with cystic fibrosis. Clin Res 72:552A
Boyle BJ, Long WB, Huang N, Widzer SJ, Balistreri WF (1979) Effect of Cimetidine and pancreatic enzymes on serum and fecal bile acid and fat absorption in cystic fibrosis. Clin Res 26:612A
Saunders JHB, Drummond S, Wormsley KG (1977) Inhibition of gastric secretion in the treatment of pancreatic insufficiency. Br Med J 1:418–419
Goodchild MC, Sagarò E, Brown GA, Cruchley PM, Jukes HR, Anderson CM (1974) Comparative trial of Pancrex V forte and Nutrizym in treatment of malabsorption in cystic fibrosis. Br Med J 3:712–714
Regan PT, Malagelada JR, Di Magno EP, Go VLW (1978) Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to pancreatic insufficiency. Gastroenterology 74:468
Morgan RGH, Hoffman NE (1971) The interaction of lipase, lipase cofactor and bile salts in triglyceride hydrolysis. Biochim Biophys Acta 248:143–148
Hofmann AF (1978) Lipase, colipase, amphipatic dietary proteins, and bile acids: new interactions at an older interface. Gastroenterology 75:530–532
Worning H (1980) The effect of enzyme substitution in patients with pancreatic insufficiency. Scand J Gastroenterol 15:529–533
Ihse I, Lilja P, Lundquist I (1980) Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy. Scand J Gastroenterol 15:137–144
Jordan PH, Grossman MI (1959) Effect of dosage schedule on the efficacy of substitution therapy in pancreatic insufficiency. Gastroenterology 36:447–451
Kaiser MH, Leite CA, Warren WD (1968) Fat assimilation after massive distal pancreatectomy. N Engl J Med 279:570–576
Di Magno EP, Go VLW, Summerskill WHJ (1973) Relations between pancreatic enzyme output and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815
Beck K (1978) Pankreasfermentsubstitution. Diskussion. In: Bartelheimer H, Classen M, Ossenberg FW (eds) Die Behandlung der kranken Bauchspeicheldrüse. Thieme, Stuttgart, p 90
Dobrilla G, Felder M (1979) Placebo: Problemstellung und praktische Auswirkungen. Dtsch Med Wochenschr 29:1023–1026
Marks IN, Banks S (1976) Part II Clinical aspects. In: Bockus HL (ed) Gastroenterology, 3rd edn, vol 3. Saunders, Philadelphia London Toronto, pp 1052–1069
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dobrilla, G., Felder, M., de Pretis, G. (1981). Pancreatic Extracts in Chronic Pancreatitis: Which, How and When?. In: Scuro, L.A., Dagradi, A., Marzoli, G.P., Pederzoli, P., Cavallini, G., Banterle, C. (eds) Topics in Acute and Chronic Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67879-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-67879-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-10439-1
Online ISBN: 978-3-642-67879-0
eBook Packages: Springer Book Archive